IL10 and serum lipopolysaccharide activity: These in vitro results, indicating that IL-10 production can be enhanced by GBZ, confirmed that our strategy of targeting eIF2α phosphorylation to limit systemic inflammation and liver failure during endotoxemia was appropriate.